- Research works
- 114 ▲ 448% vs 2013–17
- Citations
- 2.5k 22.3 per fractional work
- Top-10% rate
- 21.5% record average 16.5%
- Open access
- 44% world 28%
Not ranked overall: ImmunityBio (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 24.9×. Every wedge is a field page.
- Immunology and Microbiology 24.9×
- Biochemistry, Genetics and Molecular Biology 3.8×
- Medicine 2.4×
- Health Professions 1.1×
- Nursing 0.7×
- Mathematics 0.4×
- Psychology 0.3×
- Agricultural and Biological Sciences 0.3×
- Materials Science 0.3×
- Environmental Science 0.3×
- Economics, Econometrics and Finance 0.1×
- Computer Science 0.1×
- Neuroscience 0.1×
- Social Sciences 0.0×
Who are the top researchers at ImmunityBio (United States)?
Ranked on the composite score, Shahrooz Rabizadeh, Patrick Soon‐Shiong and Charles Vaske lead among researchers whose main affiliation is ImmunityBio (United States).
- 1 Shahrooz Rabizadeh United States · #328,165 worldwide 33 citations · 23 works
- 2 Patrick Soon‐Shiong United States · #714,468 worldwide 73 citations · 46 works
- 3 Charles Vaske United States · #1,489,586 worldwide 0 citations · 16 works
Which keywords describe research at ImmunityBio (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Tumor Regression, Cancer Immunotherapy, Natural Killer Cells, NK Cell Recognition, Tumor Microenvironment, Lymphoma and CAR T Cells.
- Immune Response
- Guidelines
- Warburg Effect
- HIF-1
- Tumor Antigen
- Dendritic Cells
- Bacterial Therapy
- Chemotherapy
- Immune Checkpoint Blockade
- Immunity
- CAR T Cells
- Tumor Microenvironment
- NK Cell Recognition
- Tumor Regression
- Immunotherapy
- Cancer Immunotherapy
- Natural Killer Cells
- Lymphoma
- Chimeric Antigen Receptor
- Gene Therapy
- PD-1 and PD-L1
- Antigen Presentation
- Tumor Targeting
- Innate Immunity
- Vaccine
- Neoadjuvant Therapy
- Cancer
- Prostate Cancer
- Inflammation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 29 words, with their numbers
- Immunotherapy7▲ 29×7 topics
- Tumor Regression4▲ 126×2 topics
- Cancer Immunotherapy4▲ 87×3 topics
- NK Cell Recognition4▲ 201×1 topic
- Natural Killer Cells4▲ 201×1 topic
- Tumor Microenvironment4▲ 30×6 topics
- Lymphoma3▲ 59×2 topics
- CAR T Cells3▲ 116×1 topic
- Chimeric Antigen Receptor3▲ 116×1 topic
- Immunity3▲ 20×6 topics
- Gene Therapy2▲ 35×3 topics
- Immune Checkpoint Blockade2▲ 57×1 topic
- PD-1 and PD-L12▲ 57×1 topic
- Chemotherapy2▲ 8.5×7 topics
- Antigen Presentation2▲ 65×2 topics
- Bacterial Therapy2▲ 145×1 topic
- Tumor Targeting2▲ 29×1 topic
- Dendritic Cells2▲ 52×1 topic
- Innate Immunity2▲ 15×2 topics
- Tumor Antigen2▲ 76×1 topic
- Vaccine1▲ 10×4 topics
- HIF-11▲ 69×1 topic
- Neoadjuvant Therapy1▲ 18×4 topics
- Warburg Effect1▲ 69×1 topic
- Cancer1▲ 2.9×9 topics
- Guidelines1▲ 7.5×2 topics
- Prostate Cancer1▲ 27×2 topics
- Immune Response1▲ 5.5×6 topics
- Inflammation1▲ 1.50×10 topics
Which research topics does ImmunityBio (United States) publish most on?
By volume in 2022–2025: Immune Cell Function and Interaction, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and Cancer Research and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immune Cell Function and Interaction Immunology 4 works
- 2 CAR-T cell therapy research Oncology 3 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 4 Cancer Research and Treatments Biotechnology 2 works
- 5 Immunotherapy and Immune Responses Immunology 2 works
- 6 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
- 7 T-cell and B-cell Immunology Immunology 1 works
- 8 Bladder and Urothelial Cancer Treatments Surgery 1 works
- 9 HIV Research and Treatment Virology 1 works
- 10 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has ImmunityBio (United States)'s research output changed?
Output in 2018–2022 was 448% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Culver City
- West Los Angeles College
- Antioch University Los Angeles
- Prototypes (United States)
- Sports Concussion Institute
- SoHaR (United States)
- Scalable Network Technologies (United States)
- World Molecular Imaging Society
- APIC (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.